- 081MarketSource · Medical Device Network
Harnessing medtech market alliances, ŌURA sets IPO plans in motion
Oura, maker of the Oura Ring wearable health device, is planning an initial public offering following a $900 million funding round completed in October 2025 that valued the company at $11 billion. The IPO announcement reflects growing investor interest in consumer-facing medtech platforms and wearable health monitoring.
- 082MarketSource · Mobi Health News
Oura confidentially files for IPO as revenue growth soars
Oura, maker of health-tracking rings, has confidentially filed for an initial public offering with the SEC, seven months after closing a $900 million funding round that valued the company at approximately $11 billion. The filing follows reported strong revenue growth for the Finnish-American wearable vendor.
- 083MarketSource · Medical Device Network
Neurosoft Bioelectronics raises $7.5m to progress BCI development
Neurosoft Bioelectronics has raised $7.5 million in funding to support clinical trials and US commercialisation of its brain-computer interface (BCI) technology. The capital will advance the company's development and regulatory pathway for its neurotechnology platform.
- 084MarketSource · Medical Device Network
Medtronic to acquire SPR Therapeutics for $650m
Medtronic announced an agreement to acquire SPR Therapeutics for approximately $650 million in upfront cash. The deal expands Medtronic's chronic pain treatment portfolio, adding SPR's neuromodulation and pain-management technologies to the company's existing offerings in that therapeutic area.
- 085MarketSource · Mobi Health News
Neurosoft Bioelectronics garners $7.5M for brain-computer interface technology
Neurosoft Bioelectronics closed a $7.5 million seed funding round led by Skybound Venture Capital, bringing total funding to over $20 million. The company is developing minimally invasive brain-computer interface technology. The round was oversubscribed and included participation from IAG Capital Partners, Connecticut Innovations, and PL Capital.
- 086MarketSource · Healthcare IT News
Qualtrics eyes a data engine to predict the experiences patients want
Qualtrics completed its $6.75 billion acquisition of Press Ganey Forsta and plans to expand its human-experience-management platform by leveraging what it describes as the largest HX dataset globally. The company intends to integrate AI capabilities to shift experience management from reactive measurement to predictive analytics across industries, including healthcare applications focused on anticipating patient needs and aligning delivery with consumer expectations.
- 087MarketSource · Medical Device Network
Cagent Vascular raises $41m for dual-modality IVL platform advancement
Cagent Vascular raised $41 million in funding to advance its Serranator SONIC intravascular lithotripsy (IVL) system. The capital will support completion of a pivotal clinical trial and commercial readiness for the dual-modality platform, which combines sonic and mechanical energy to treat calcified lesions in coronary and peripheral vessels.
- 088MarketSource · Medical Device Network
Endologix purchases thrombectomy system from Surmodics
Endologix acquired the Pounce mechanical thrombectomy system from Surmodics, expanding its vascular intervention product portfolio. The acquisition adds a minimally invasive clot-removal device to Endologix's existing vascular and endovascular offerings.
- 089MarketSource · Mobi Health News
Alcidion buys Telstra Health patient flow assets and more briefs
Alcidion, an ASX-listed vendor, has agreed to acquire Telstra Health's Kyra patient flow solutions suite, which includes Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ. The acquisition expands Alcidion's enterprise patient flow software across Australia. Kyra products support inpatient and outpatient workflows including bed management, patient check-ins, wayfinding, referral management, triage, billing, data consolidation, and operational reporting.
- 090MarketSource · Medical Design & Outsourcing
AP Technologies acquires Blueacre Technology
AP Technologies acquired Blueacre Technology, an Ireland-based specialist in laser micromachining and nitinol processing for medical devices. The deal establishes AP Technologies' first European operation and expands its catheter platform to include laser-processed metallic components for minimally invasive surgical devices.
- 091MarketSource · Medical Design & Outsourcing
Robotics expert Brian Miller on product development, AI and what he learned at Intuitive
Brian Miller, former executive vice president and chief digital officer at Intuitive Surgical, has joined Sovato as CEO. Miller spent a long career at Intuitive, the leading surgical robotics company, and is now leading Sovato's efforts to scale telesurgery platforms. The move reflects executive-level shifts in the surgical robotics and digital surgery sector.
- 092MarketSource · Mobi Health News
Commure raises $70M, boosting post-money valuation to $7B
Commure, an AI-enabled healthcare software company, raised $70 million in Series D funding led by General Catalyst, bringing total funding to $750 million and post-money valuation to $7 billion. The company and its subsidiary Athelas provide AI tools to help healthcare providers with administrative workflows.
- 093MarketSource · Medical Device Network
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific announced a $1.5 billion investment to acquire a 34% equity stake in MiRus, a developer of implants and procedural solutions. The investment underscores Boston Scientific's strategy to expand its portfolio in implantable devices and minimally invasive procedural technologies.
- 094MarketSource · Healthcare IT News
Epic gains ground as acute care EHR purchasing slows
Acute care electronic health record purchasing activity declined sharply in 2025 as health systems deferred major platform decisions due to economic pressure, policy uncertainty, and increased investment in AI technologies. Epic expanded its market share during the slowdown in overall EHR procurement.
- 095MarketSource · Medical Device Network
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Artivion has completed a $135 million acquisition of Endospan following US regulatory approval of Nexus, an endovascular device for aortic arch syndrome treatment. The deal, structured under a 2019 agreement, expands Artivion's portfolio in the aortic intervention space and adds Endospan's technology platform to its surgical and interventional cardiology offerings.
- 096MarketSource · Medical Device Network
Embecta acquires Owen Mumford for $172.6m
Embecta completed its acquisition of UK-based Owen Mumford Holdings for $172.6 million. Owen Mumford is a medical device manufacturer whose product portfolio spans injection devices, diagnostic sampling systems, and drug delivery solutions. The deal expands Embecta's capabilities in patient-centric device design and drug delivery platforms.
- 097MarketSource · MedCity News
IKS Health Acquires ARAI to Build Out Specialized AI Stack
IKS Health has acquired healthcare AI startup ARAI to expand its automation technology capabilities and reduce reliance on third-party AI models. The acquisition strengthens IKS Health's proprietary AI infrastructure for its automation tools used across healthcare operations.
- 098MarketSource · Mobi Health News
9amHealth raises $26M for virtual specialty care platform and more funding news
9amHealth, a virtual specialty care platform focused on cardiometabolic health, closed a $26 million Series B round led by Define Ventures, with participation from SemperVirens, Catalio Capital Management, and NewHealth Ventures. The funding will support platform growth and enhancement. Define Ventures' founder will join the board.
- 099MarketSource · Medical Device Network
Butterfly Medical raises $21m in funds for BPH device development
Butterfly Medical closed a $21 million Series C funding round to advance development and commercialization of its minimally invasive benign prostatic hyperplasia (BPH) treatment device. The funding supports the company's effort to bring the urology-focused technology to market.
- 100MarketSource · Medical Device Network
BlueWind Medical raises $47.8m to advance commercialisation efforts for UUI treatment
BlueWind Medical closed a $47.8 million funding round to accelerate commercialisation of its Revi implantable tibial neuromodulation system for urge urinary incontinence treatment. Proceeds will fund expanded sales operations and market access initiatives.
- 101MarketSource · Medical Device Network
Ardent Health and Fujifilm team up for Synapse enterprise imaging rollout
Ardent Health, an acute care hospital operator across six US states, has partnered with Fujifilm Healthcare to deploy Synapse enterprise imaging solutions across its facilities. Synapse is an enterprise platform for managing medical imaging data and workflows across health systems.
- 102MarketSource · Medical Design & Outsourcing
Tecomet and Orchid complete merger, form global platform
Tecomet and Orchid Orthopedic Solutions completed their merger, creating a scaled global manufacturing platform. The combination is positioned to strengthen technical capabilities, expand global footprint, and improve supply resilience for OEM customers across medical device manufacturing.
- 103MarketSource · MedCity News
Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously
Shyld AI raised $13.4 million to expand its AI-powered UV disinfection platform that autonomously sanitizes hospital rooms. The technology targets reduction of hospital-acquired infections and reduces dependence on manual cleaning labor.
- 104MarketSource · Medical Device Network
UroMems eyes regulatory filings for SUI treatment after $60m fundraise
UroMems raised $60 million in funding to advance its UroActive system toward regulatory submission for stress urinary incontinence treatment. The company plans to use the capital to complete a pivotal trial supporting FDA and CE mark applications in the US and Europe.
- 105MarketSource · Medical Device Network
Rivermark pockets $20m in Series D for late-stage prostate device trial
Rivermark Medical raised $20 million in Series D funding to advance its pivotal trial for FloStent, a device designed to treat benign prostatic hyperplasia. The capital will support late-stage clinical development of the minimally invasive urology device.
- 106MarketSource · Medical Design & Outsourcing
Velosity launches innovation lab in Minnesota
Velosity opened a 5,000 sq ft innovation lab at its Brooklyn Park, Minnesota machining center of excellence, a multi-million-dollar facility that began development in September. The lab supports Velosity's contract manufacturing and product development capabilities for medical device makers.
- 107MarketSource · Medical Design & Outsourcing
Nissha breaks ground on manufacturing expansion in Wisconsin
Nissha Medical Technologies, the medical devices unit of Japan's Nissha Co., broke ground on a new 50,000-square-foot manufacturing facility in New Richmond, Wisconsin. The expansion targets its micro molding operations to increase capacity for miniaturized, precision-molded components in response to growing demand.
- 108MarketSource · Medical Device Network
Latest foreign investment in UK highlights underserved potential of primary care technology
Doctolib, a European digital health supplier, has acquired Medicus, a UK-based NHS GP technology provider, as part of a broader expansion strategy in the UK market. The deal underscores growing investor interest in primary care technology infrastructure.
- 109MarketSource · Mobi Health News
Omada Health reports 42% revenue growth in Q1 2026 earnings
Omada Health, a San Francisco-based virtual care platform specializing in chronic disease management for diabetes, cardiometabolic conditions, hypertension, and musculoskeletal disorders, reported 42% year-over-year revenue growth in Q1 2026, one year after its NASDAQ debut. The company delivers behavior-change coaching and health tracking capabilities to its user base.
- 110MarketSource · Mobi Health News
Latest Middle East partnerships expanding Korean health tech and more briefs
South Korean medtech firms ROKIT Healthcare and Seers have signed partnerships with Middle Eastern healthcare companies to expand their AI-enabled monitoring and diagnostic technologies. ROKIT Healthcare licensed its chronic kidney disease prediction AI algorithm to Saudi Arabia-based LifeHope for integration into its Longevity platform, while Seers expanded its inpatient monitoring capabilities through a separate regional partnership.
- 111MarketSource · Medical Device Network
BD uplifts FY26 revenue outlook based on steady portfolio performance
Becton Dickinson raised its FY26 revenue guidance, reversing a prior downward revision from Q1 that stemmed from the divestiture of its diagnostics business to Waters Corporation. The uplift reflects improved performance across BD's remaining portfolio.
- 112MarketSource · Medical Device Network
Roche to acquire PathAI in $1.05bn deal
Roche signed a definitive merger agreement to acquire PathAI for up to $1.05 billion. PathAI develops AI-powered digital pathology software for analyzing histopathology images. The acquisition expands Roche's diagnostics and AI capabilities in pathology and precision medicine.
- 113MarketSource · MedCity News
Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships
Rosarium Health, a startup focused on aging-in-place solutions, closed a $6 million seed round led by Kalos Ventures with participation from ResilienceVC, Rock Health Capital, and others. The company simultaneously announced new partnerships with Massachusetts and Medicaid programs to expand access to its homecare platform.
- 114MarketSource · Medical Device Network
BD and Wellstar partner to improve hospital medication delivery systems
BD and Wellstar Health System have announced a partnership to enhance medication delivery safety and efficiency across Wellstar's hospital and care facility network. The collaboration aims to optimize medication management processes and reduce errors in drug administration.
- 115MarketSource · Mobi Health News
HealthVerity to acquire data platform Symphony Health
HealthVerity announced plans to acquire Symphony Health, a commercial healthcare data and analytics platform. The combined entity will integrate clinical data with commercial insights to serve life sciences companies, payers, and government entities seeking real-world data, patient research recruitment, and cross-dataset record linkage capabilities.
- 116MarketSource · Mobi Health News
Exclusive: XCaliber Health scores $6.5M for workflow platform
XCaliber Health raised $6.5 million in seed funding for its agentic AI platform designed to reduce administrative burden in healthcare settings. The funding will support nationwide expansion of the workflow automation platform.
- 117MarketSource · Medical Device Network
Olympus to distribute EndoRobotics’ technologies worldwide
Olympus has secured an exclusive global distribution agreement for EndoRobotics' robot-assisted technologies, integrating them into its EndoTherapy product portfolio. The deal expands Olympus's surgical robotics offerings to healthcare providers worldwide.
- 118MarketSource · Medical Design & Outsourcing
Confluent Medical Technologies opens nitinol wire manufacturing facility in India
Confluent Medical Technologies opened a 26,000-square-foot nitinol wire manufacturing facility in Hyderabad, India, doubling its production capacity for the material. The Nitinol Wire Center of Excellence represents the contract manufacturer's investment in expanding supply of nitinol, a shape-memory alloy used in minimally invasive devices and guidewires.
- 119MarketSource · Mobi Health News
Enzo Health raises $20M to expand AI home health platform
Enzo Health, a home health and post-acute care platform using AI, closed a $20 million Series A funding round led by N47, with participation from Gradient, Tandem Ventures, and Rigby Watts. The capital will support expansion of the company's AI-driven home health offerings. Total funding to date is $26 million.
- 120MarketSource · Medical Device Network
Stryker maintains FY26 outlook despite cyberattack-impacted Q1
Stryker experienced a cyberattack in March 2026 that disrupted operations and impacted first-quarter performance. Despite the incident, the company maintained its full-year 2026 financial outlook, indicating management confidence in recovery and continued execution of business plans.